Grundinformationen
- Standard-SMILES
CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1- InChIKey
SFBODOKJTYAUCM-UHFFFAOYSA-N- Summenformel
- C18H16O3
- Durchschnittliche Molmasse
- 280,3 g/mol
- Monoisotopische Masse
- 280,10994437
Namen und Bezeichner
- Bevorzugter Name
- Ipriflavone
- IUPAC
- 3-phenyl-7-propan-2-yloxychromen-4-one
- Englischer Name
- Ipriflavone
- Summenformel
- C18H16O3
- Molmasse
- 280.32
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
35212-22-7- PubChem CID
- 3747
- DTXSID
DTXSID5040679- ChEMBL
CHEMBL165790- ChEBI
CHEBI:31719- UNII
- 80BJ7WN25Z
- EC Number
- 609-092-2
- Nikkaji
- J19.468I
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 4
- Polarare Oberfläche (TPSA)
- 35,5 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 21
- Formalladung
- 0
- Komplexität
- 407
Experimentelle und physikochemische Eigenschaften
Collision Cross Section
161.54 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];175.72 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];155.27 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
164.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Physikochemische Eigenschaften
- Schmelzpunkt
- 116 · 116-120 °C(lit.)
- Siedepunkt
- 363.04 °C · 363.04°C (rough estimate)
- Dichte
- 1.217 · 1.2170 (rough estimate)
- Brechungsindex
- 1.47 · 1.4700 (estimate)
- storage temp.
- Sealed in dry,Room Temperature
- Löslichkeit
- 20 · DMF:20.0(Max Conc. mg/mL);71.35(Max Conc. mM)DMF:PBS (pH 7.2) (1:4):0.2(Max Conc. mg/mL);0.71(Max Conc. mM)DMSO:33.11(Max Conc. mg/mL);118.11(Max Conc. mM)Ethanol:1.5(Max Conc. mg/mL);5.35(Max Conc. mM)
- Aggregatzustand
- powder to crystal
- Farbe
- White to Almost white
- Merck
- 14 · 14,5074
- InChI
- InChI=1S/C18H16O3/c1-12(2)21-14-8-9-15-17(10-14)20-11-16(18(15)19)13-6-4-3-5-7-13/h3-12H,1-2H3
- InChIKey
- SFBODOKJTYAUCM-UHFFFAOYSA-N
- SMILES
- C1OC2=CC(OC(C)C)=CC=C2C(=O)C=1C1=CC=CC=C1
- LogP
- 4.245 · 4.245 (est)
- CAS Datenbank
- 35212 · 35212-22-7(CAS DataBase Reference)
Sicherheit und Regulatorisches
Sicherheitsdaten
- wgk
- 2
- hs_code
- 29329990
- RTECS-Nr.
- DJ3100500
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 24/25-36/37/39-27-26
- Speicherklasse
- 11 - Combustible Solids
Chemie und Industrie
Pharmakologische Informationen
ATC Code
M - Musculo-skeletal system;M05 - Drugs for treatment of bone diseases;M05B - Drugs affecting bone structure and mineralization;M05BX - Other drugs affecting bone structure and mineralization;M05BX01 - Ipriflavone
QM - Musculo-skeletal system;QM05 - Drugs for treatment of bone diseases;QM05B - Drugs affecting bone structure and mineralization;QM05BX - Other drugs affecting bone structure and mineralization;QM05BX01 - Ipriflavone
Anwendungen
BeschreibungIpriflavone, a derivative of isoflavone, is a calcium metabolism regulator useful in the treatment of primary and secondary osteoporosis, as well as disorders of osteogenesis. It appears to be without significant side-effects.
Verwenden7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one (Ipriflavone) has been used as a model drug in a study to functionalize the mesoporous bioactive glasses (MBG). Study suggested that since ipriflavone is a hydrophobic anti-osteoporotic drug, it easily attaches to the surface of MBG and results in long-term drug delivery.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Anbieter50 Anbieter
Ergänzende Hinweise
DefinitionChEBI: Ipriflavone is a member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women. It has a role as a bone density conservation agent. It is a member of isoflavones and an aromatic ether.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…